Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TJ-50 for postoperative chronic sinusitis after endoscopic sinus surgery
jRCTs031180048Completed
- Sponsor
- Tsumura & Co.
- Start
- Sep 2018
- Countries
- 1
01
Overview
Randomised, open-label trial of keigairengyoto in rhinosinusitis (2 arms), sponsored by Tsumura & Co. Primary endpoint: Change in SNOT-22 score at 3 months after ESS. Started Sep 2018; status: completed.
02
Drugs
keigairengyoto
03
Conditions
rhinosinusitis
Beyond the preview
Go deeper on jRCTs031180048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180048.